ESPE Abstracts (2022) 95 RFC1.1

1Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, Utrecht, Netherlands; 2Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands; 3Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; 4The Oncologic and Reconstructive Surgery Clinic, M. Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland; 5Department of Paediatric Endocrinology and Diabetes, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, United Kingdom; 6Endocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 7Department of Clinical Genetics, Guy's and St Thomas’ NHS Foundation Trust, London, United Kingdom; 8Institute of Experimental Pediatric Endocrinology, Charité - Universitätsmedizin, Berlin, Germany; 9Medical Faculty, Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany; 10Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany; 11Thyroid Therapy Unit, The Royal Marsden NHS Foundation Trust, Hospital, London, United Kingdom; 12Department of Nuclear Medicine, EO Ospedali Galliera, Genoa, Italy; 13University Hospital of São João, Medical Faculty and Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal; 14Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan; 15Department of Pediatric Endocrinology, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands; 16Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, Netherlands

At present no European recommendations for the management of pediatric thyroid nodules and differentiated thyroid carcinoma (DTC) exist. Differences in clinical, molecular, and pathological characteristics between pediatric and adult DTC emphasize the need for specific recommendations for the pediatric population. An expert panel was instituted by the executive committee of the European Thyroid Association (ETA) including an international community of experts from a variety of disciplines including pediatric and adult endocrinology, pathology, endocrine surgery, nuclear medicine, clinical genetics, and oncology. The American Thyroid Association (ATA) pediatric guideline 2015 was used as framework for the present guideline. Areas of discordance were identified, clinical questions were formulated and literature searches were performed. The expert panel members discussed the evidence and formulated recommendations based upon the latest evidence and expert opinion. Children with a thyroid nodule or DTC require expert care in an experienced center. The present guideline provides guidance for healthcare professionals to make well-considered decisions together with patients and parents regarding diagnostics, treatment and follow-up of pediatric thyroid nodules and DTC.

Volume 95

60th Annual ESPE (ESPE 2022)

Rome, Italy
15 Sep 2022 - 17 Sep 2022

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.